Last edition
News about
Immunofoco's IMC001 CAR-T Therapy Receives Dual FDA and CDE Approvals for Gastrointestinal Tumors
IMC001 is an autologous CAR-T cell product targeting EpCAM for infusion, designed to treat EpCAM-positive advanced gastrointestinal tumors, including advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Everest Medicines' Partner Pfizer's VELSIPITY Receives Approval from European Commission
This approval allows for the treatment of patients 16 years of age and older with moderately to severely active UC who have had an inadequate response, lost response, or were intolerant to conventional therapy or a biological agent.
Pfizer and Americares India Foundation Announce Remarkable Success of Project Parivartan
The project aimed at demonstrating reduction in infections and in prevalence of multi-drug resistant organisms in small to mid-sized hospitals through infection prevention and control and antimicrobial stewardship activities.
Jubilant HollisterStier Expands Facility, Adds Third Sterile Fill Finish Line
The expansion initiative encompasses the installation of a new high-speed commercial fill finish line, housed within a 50,000 square foot facility expansion.
X-trodes' Smart Skin Receives FDA Clearance for Wireless Wearable Monitoring Technology
This innovative technology represents a new era in wearable monitoring, offering advanced electrophysiological data acquisition without the need for cumbersome wires or gels.
Avidity Biosciences' AOC 1044 Receives Rare Pediatric Disease Designation for DMD Treatment
AOC 1044, currently undergoing assessment in the Phase 1/2 EXPLORE44™ trial, is the first of multiple Antibody Oligonucleotide Conjugates (AOCs™) developed by Avidity for DMD.
Thermo Fisher Scientific Receives Five Awards in Annual CDMO Leadership Awards
The awards, based on evaluations from customers who worked with contract manufacturers over the past 18 months, involved a rigorous assessment of 98 companies across 23 performance metrics.
This agreement marks a pivotal step in Fusion's journey towards developing next-generation radiopharmaceuticals as precision medicines.
St. Elizabeth Healthcare First in Kentucky to Implant New Device To Treat Abnormal Heart Rhythm
The Aurora EV-ICD system is manufactured by Medtronic and was approved for use by the Food and Drug Administration (FDA) in October 2023.
Novartis AG Initiates Strategic Review of Novartis India Limited
While the strategic review progresses, it is essential to recognize that there is no guarantee of its completion within 2024.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy